The AI In Cancer Diagnostics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The AI In Cancer Diagnostics Market:
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
According to The Business Research Company’s AI In Cancer Diagnostics Global Market Report 2024, The ai in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.55 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of ai applications beyond imaging.
The ai in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to emergence of explainable ai, global increase in healthcare it spending, integration with electronic health records (ehr), personalized medicine adoption, continued advances in ai algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.
The increasing prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market going forward. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. The integration of AI in cancer care aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving outcomes for cancer patients. For instance, in May 2021, according to the National Library of Medicine, a US-based medicine library, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with many deaths. Therefore, the increasing prevalence of cancer is driving the growth of artificial intelligence in the cancer diagnostics market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp
The ai in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types
3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring
4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations
Major companies operating in the AI in cancer diagnostics market are experiencing significant growth due to advancements in AI-powered digital pathology solutions for cancer diagnosis. AI-powered digital pathology solutions for cancer diagnosis refer to the use of artificial intelligence (AI) algorithms to detect cancer and other diagnostic features in multiple tissue types, providing accurate and timely cancer diagnosis, support case prioritization, and reproducible diagnoses. For instance, In November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, launched an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to improve accuracy, provide AI-powered decision support tools, streamline reporting, enhance laboratory efficiency, and increase diagnostic confidence.
The ai in cancer diagnostics market report table of contents includes:
- Executive Summary
- AI In Cancer Diagnostics Market Characteristics
- AI In Cancer Diagnostics Market Trends And Strategies
- AI In Cancer Diagnostics Market - Macro Economic Scenario
- Global AI In Cancer Diagnostics Market Size and Growth
.
.
.
- Global AI In Cancer Diagnostics Market Competitive Benchmarking
- Global AI In Cancer Diagnostics Market Competitive Dashboard
- Key Mergers And Acquisitions In AI In Cancer Diagnostics Market
- AI In Cancer Diagnostics Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Microsoft Corporation
- IBM Corporation
- Babylon Healthcare Services Ltd.
- Verily Life Sciences LLC
- Tempus
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
